Spotlight on Applicability Domain, Quantitative Potency Assessment and Medical Devices In case you missed SenzaGen’s poster presentations and scientific session at this year’s SOT, we are pleased to offer you a new opportunity to […]
Spotlight on in vitro quantitative assessment of skin sensitizing potency. Join our upcoming webinar to explore the recent advancement in GARD® for quantitative assessment of skin sensitizing potency. This session […]
Spotlight on Point-of-Departure, Challenging Substances, and Active Ingredients We invite you to join our upcoming webinar, where industry leaders from Lundbeck, Unilever, and Cargill, along with experts from SenzaGen will […]
Join us for a special re-run of our popular GARD® webinar to explore the recent advancement in Skin Sensitization testing, focusing on substances that fall outside the applicability domains of […]
Join SenzaGen and industry leaders from Clarins and Bic Skin Creative for an in-depth webinar on using GARD® assays for skin sensitization testing. Learn how this innovative technology overcomes the unique challenges […]
Join us for an insightful webinar on the evolving role of New Approach Methodologies (NAMs) in regulatory biological safety assessments and how they can be used to help develop safe […]
Advancing NAMs for Skin Sensitization Testing: Natural Extracts, Medical Devices and Potency Join our upcoming webinar, where SenzaGen’s expert and guest speakers from dōTERRA and Risk Science Consortium will share […]
Bringing high performance and extended applicability to Defined Approaches for Skin Sensitization (DASS) Join our webcast to learn more about the inclusion of GARD®skin in OECD TG 497— what it […]
Using GARD® to derive PoDs and safe dose levels for skin sensitizers Chemicals | Natural Extracts | Complex Mixtures Join our upcoming webinar to explore how GARD® enables the derivation […]
Bringing high performance and extended applicability to Defined Approaches for Skin Sensitization (DASS) Join us for a special re-run of our popular webcast to learn more about the inclusion of […]
